92567 ⎘
Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring not being further substituted
Organic compound, three-dimensional organic framework formed by using organic compound, separation sieve and optical layer, which comprise organic framework, and optical device comprising optical layer as optical amplification layer
#2Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#3Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#4Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#5Cyclic compounds and methods of making and using the same
#6Amine derivative compounds for treating ophthalmic diseases and disorders
#7Inhibitors of the shiga toxins trafficking through the retrograde pathway
#8Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
#9ORGANIC COMPOUNDS
#10Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
#11Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#12Amine derivative compounds for treating ophthalmic diseases and disorders
#13Amine derivative compounds for treating ophthalmic diseases and disorders
#14NON-IMIDAZOLE ALKYLAMINES AS HISTAMINE H3-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS
#15CYCLOHEXYLAMINE DERIVATIVE CONTAINING PHENYL GROUP, AND THERAPEUTIC AGENT FOR DISEASES ACCOMPANIED BY CENTRAL NERVOUS SYSTEM DISORDERS
#16Inhibitors of the Shiga toxins trafficking through the retrograde pathway
#17Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
#18Aryloxy amine compounds and their use as sodium channel modulators
#19Male contraceptive
#20Amine derivative compounds for treating ophthalmic diseases and disorders
#21Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
#22THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF
#23Phenyl-Pyrazole Derivatives as Non-Steroidal Glucocorticoid Receptor Ligands
#24Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
#25Non-imidazole alkylamines as histamine H- receptor ligands and their therapeutic applications
#26Processes for the preparation of atomoxetine hydrochloride
#27β2-adrenergic receptor agonists
#283-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
#29Thyronamine derivatives and analogs and methods of use thereof
#30Isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards
#31Processes for the preparation of tomoxetine
#32Process for the optical resolution and recycling of tomoxetine
#33Enantiomerically pure atomoxetine and tomoxetine mandelate
#34Process for the preparation of atomoxetine hydrochloride
#35Thyronamine derivatives and analogs and methods of use thereof
#36β2-adrenergic receptor agonists
#37Thyronamine derivatives and analogs and methods of use thereof